References
1. Basso C, Corrado D, Bauce B, Thiene G. Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol . 2012;5:1233–1246.
2. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MGPJ, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DMY, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria. Circulation . 2010;121:1533–1541.
3. Philips B, Madhavan S, James C, Tichnell C, Murray B, Needleman M, Bhonsale A, Nazarian S, Laurita KR, Calkins H, Tandri H. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.Circ Arrhythm Electrophysiol . 2013;6:160–166.
4. Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A, Bourfiss M, Fortier A, Lie ØH, Saguner AM, Svensson A, Andorin A, Tichnell C, Murray B, Zeppenfeld K, van den Berg MP, Asselbergs FW, Wilde AAM, Krahn AD, Talajic M, Rivard L, Chelko S, Zimmerman SL, Kamel IR, Crosson JE, Judge DP, Yap S-C, van der Heijden JF, Tandri H, Jongbloed JDH, Guertin M-C, van Tintelen JP, Platonov PG, Duru F, Haugaa KH, Khairy P, Hauer RNW, Calkins H, Te Riele ASJM, James CA. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J . 2019;40:1850–1858.
5. Santangeli P, Zado ES, Supple GE, Haqqani HM, Garcia FC, Tschabrunn CM, Callans DJ, Lin D, Dixit S, Hutchinson MD, Riley MP, Marchlinski FE. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.Circ Arrhythm Electrophysiol . 2015;8:1413–1421.
6. Berruezo A, Fernández-Armenta J, Mont L, Zeljko H, Andreu D, Herczku C, Boussy T, Tolosana JM, Arbelo E, Brugada J. Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique. Circ Arrhythm Electrophysiol . 2012;5:111–121.
7. Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS, Estes III NAM, Marcus F, Scheinman MM. Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy: A Report From the North American ARVC Registry. J Am Coll Cardiol . 2009;54:609–615.
8. Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol . 2007;50:432–440.
9. Marchlinski FE. Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy. Circulation . 2004;110:2293–2298.
10. Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A, Marrouche NF, Ozduran V, Wazni OM, Elayi SC, Saenz LC, Minor S, Cummings JE, Burkhardt JD, Hao S, Beheiry S, Tchou PJ, Natale A. Short- and Long-Term Success of Substrate-Based Mapping and Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia.Circulation . 2005;111:3209–3216.
11. Garcia FC, Bazan V, Zado ES, Ren J-F, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation . 2009;120:366–375.
12. Berruezo A, Fernández-Armenta J, Mont L, Zeljko H, Andreu D, Herczku C, Boussy T, Tolosana JM, Arbelo E, Brugada J. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol . 2012;5:111–121.
13. Bai R, Di Biase L, Shivkumar K, Mohanty P, Tung R, Santangeli P, Saenz LC, Vacca M, Verma A, Khaykin Y, Mohanty S, Burkhardt JD, Hongo R, Beheiry S, Dello Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez J, Tondo C, Natale A. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol . 2011;4:478–485.
14. Yoshida K, Liu T-Y, Scott C, Hero A, Yokokawa M, Gupta S, Good E, Morady F, Bogun F. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia. J Am Coll Cardiol . 2010;56:969–979.
15. Santangeli P, Alcalde O, Zado ES, Callans DJ, Marchlinski FE. Spatial resolution of defibrillator electrograms to detect distinct exit sites of scar-related ventricular tachycardia. Pacing Clin Electrophysiol PACE . 2014;37:1256–1264.
16. Tung Roderick, Mathuria Nilesh, Michowitz Yoav, Yu Ricky, Buch Eric, Bradfield Jason, Mandapati Ravi, Wiener Isaac, Boyle Noel, Shivkumar Kalyanam. Functional Pace-Mapping Responses for Identification of Targets for Catheter Ablation of Scar-Mediated Ventricular Tachycardia.Circ Arrhythm Electrophysiol . 2012;5:264–272.
17. Philips B, Madhavan S, James C, Tichnell C, Murray B, Dalal D, Bhonsale A, Nazarian S, Judge DP, Russell SD, Abraham T, Calkins H, Tandri H. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol . 2012;5:499–505.
18. Müssigbrodt A, Dinov B, Bertagnoli L, Sommer P, Richter S, Breithardt OA, Rolf S, Bollmann A, Hindricks G, Arya A. Precordial QRS amplitude ratio predicts long-term outcome after catheter ablation of electrical storm due to ventricular tachycardias in patients with arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol . 2015;48:86–92.
19. Wei W, Liao H, Xue Y, Fang X, Huang J, Liu Y, Deng H, Liang Y, Liao Z, Liu F, Lin W, Zhan X, Wu S. Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience. PLOS ONE . 2017;12:e0169863.
20. Santangeli P, Tung R, Xue Y, Chung F-P, Lin Y-J, Di Biase L, Zhan X, Lin C-Y, Wei W, Mohanty S, Burkhardt DJ, Zado ES, Callans DJ, Marchlinski FE, Wu S, Chen S-A, Natale A. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy. JACC Clin Electrophysiol . 2019;5:55–65.
21. Mahida S, Venlet J, Saguner AM, Kumar S, Baldinger SH, AbdelWahab A, Tedrow UB, Castelletti S, Pantazis A, John RM, McKenna WJ, Lambiase PD, Duru F, Sapp JL, Zeppenfeld K, Stevenson WG. Ablation compared with drug therapy for recurrent ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: Results from a multicenter study.Heart Rhythm . 2019;16:536–543.
22. Mathew S, Saguner AM, Schenker N, Kaiser L, Zhang P, Yashuiro Y, Lemes C, Fink T, Maurer T, Santoro F, Wohlmuth P, Reißmann B, Heeger CH, Tilz R, Wissner E, Rillig A, Metzner A, Kuck K, Ouyang F. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.J Am Heart Assoc [Internet]. 2019 [cited 2021 Mar 5];8. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.118.010365
23. Lin C, Chung F, Kuo L, Lin Y, Chang S, Lo L, Hu Y, Tuan T, Chao T, Liao J, Chang T, Yamada S, Te ALD, Huang T, Chen S. Characteristics of recurrent ventricular tachyarrhythmia after catheter ablation in patients with arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Electrophysiol . 2019;30:582–592.
Table. Principal studies documenting the efficacy of endo-epicardial catheter ablation of VT in ARVC.